Showing results (361-370 of 376) with videos related to

Sort By:
Pageof 38
Nature Medicine|September 30, 1999
Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphomaM Bendandi, C D Gocke, C B Kobrin, et al.
Medical and Pediatric Oncology|September 1, 1997
Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte SocietyB E Favara, A C Feller, M Pauli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2000
New malignant diseases after allogeneic marrow transplantation for childhood acute leukemiaG Socié, R E Curtis, H J Deeg, et al.
Blood|August 15, 1996
A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphomaM J Stone, E A Sausville, J W Fay, et al.
International Journal of Cancer|February 27, 1999
A study of adult T-cell leukemia/lymphoma incidence in central BrooklynP H Levine, H Dosik, E M Joseph, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2016
Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancerC A Carter, A Rajan, C Keen, et al.
The New England Journal of Medicine|February 24, 2001
Gene-expression profiles in hereditary breast cancerI Hedenfalk, D Duggan, Y Chen, et al.
Blood|June 22, 2001
The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosisS E Straus, E S Jaffe, J M Puck, et al.
International Journal of Cancer|May 20, 2016
Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750-an antisense oligonucleotide against eIF4E-in combination with irinotecan in solid tumors and irinotecan-refractory colorectal cancerA G Duffy, O V Makarova-Rusher, S V Ulahannan, et al.
Leukemia|July 9, 2016
Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphomaA Bouska, W Zhang, Q Gong, et al.
Pageof 38